Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Hennion & Walsh Asset Management Inc.

Hennion & Walsh Asset Management Inc. raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,237 shares of the medical equipment provider’s stock after acquiring an additional 907 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in Intuitive Surgical were worth $6,909,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Massachusetts Financial Services Co. MA purchased a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $558,807,000. International Assets Investment Management LLC boosted its holdings in shares of Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the period. FMR LLC grew its position in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB raised its position in Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Finally, State Street Corp boosted its stake in Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after purchasing an additional 210,363 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $582.01 on Thursday. The stock has a 50-day simple moving average of $537.05 and a 200-day simple moving average of $496.50. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $584.60. The stock has a market capitalization of $207.30 billion, a P/E ratio of 93.57, a PEG ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on ISRG shares. Leerink Partners upped their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Wells Fargo & Company increased their price objective on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 11th. Piper Sandler reissued an “overweight” rating and issued a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Raymond James lifted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Finally, Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the completion of the sale, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. The trade was a 88.63 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock valued at $25,012,927 in the last quarter. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.